effect of botulinum neurotoxin a injection into the submucoperichondrium of the nasal septum in reducing idiopathic non-allergic rhinitis and persistent allergic rhinitis
نویسندگان
چکیده
introduction: submucoperichondrial injection of botulinum neurotoxin a (bta) in the nasal septum is a promising therapeutic option in the treatment of persistent allergic rhinitis (ar) and non-allergic rhinitis, and is safer and more effective than intraturbinate injection in reducing clinical symptoms. materials and methods: forty patients diagnosed with persistent ar or non-allergic rhinitis referred to shafa medical center affiliated to kerman university of medical sciences were included in this study and were randomly allocated to the intervention or control groups. patients received an injection of 80 units bta (dysport, ipsen ltd company, uk) at a concentration of 200 mu/ml in normal saline on four spots in each side of the nose and were followed for 12 weeks. data were analyzed using a chi-square or fisher’s test, and mann whitney u test. results: the mean age of patients was 46.1±15.3 years, and the two groups did not differ significantly in demographic variables. the severity of rhinitis symptoms was reduced after 4 weeks of injections in the intervention group and then gradually decreased further until the 12th week. there was a statistically significant difference between the groups (p<0.05). no adverse effects were reported. conclusion: submucoperichondrial bta injection can be considered an effective therapeutic option in patients with persistent ar and idiopathic rhinitis. in comparison with other injection techniques, submucoperichondrial bta injection has fewer side effects with a longer period of effectiveness, and is easy to perform and is more tolerable for the patient.
منابع مشابه
Effect of Botulinum Neurotoxin A Injection into the Submucoperichondrium of the Nasal Septum in Reducing Idiopathic Non-Allergic Rhinitis and Persistent Allergic Rhinitis
Introduction: Submucoperichondrial injection of botulinum neurotoxin A (BTA) in the nasal septum is a promising therapeutic option in the treatment of persistent allergic rhinitis (AR) and non-allergic rhinitis, and is safer and more effective than intraturbinate injection in reducing clinical symptoms. Materials and Methods: Forty patients diagnosed with persistent AR or non-allergic rhiniti...
متن کاملEffect of Botulinum Neurotoxin A Injection into the Submucoperichondrium of the Nasal Septum in Reducing Idiopathic Non-Allergic Rhinitis and Persistent Allergic Rhinitis
INTRODUCTION Submucoperichondrial injection of botulinum neurotoxin A (BTA) in the nasal septum is a promising therapeutic option in the treatment of persistent allergic rhinitis (AR) and non-allergic rhinitis, and is safer and more effective than intraturbinate injection in reducing clinical symptoms. MATERIALS AND METHODS Forty patients diagnosed with persistent AR or non-allergic rhinitis ...
متن کاملThe Effect of Gelfoam Impregnated With Botulinum Toxin on Allergic Rhinitis Symptoms
Introduction: This study evaluated the effect of gelfoam impregnated with botulinum toxin on the symptoms induced by allergic rhinitis. Materials and Methods: In total, 30 patients with allergic rhinitis who did not respond to common therapies were included in this clinical trial study. All patients were treated with intranasal gelfoam impregnated with botulinum toxin type a (...
متن کاملThe Prevalence of Allergic Rhinitis in Patients with Chronic Rhinosinusitis
Introduction: Chronic rhinosinusitis (CRS) is a multifactorial disease. Allergies are considered a predisposing factor to CRS; however, this remains controversial. The objective of this research was to investigate the prevalence of co-morbidities and allergic reaction, and to specify the most common allergens in patients with confirmed CRS. Materials and Methods: One hundred patients with sig...
متن کاملManagement of Rhinitis: Allergic and Non-Allergic
RHINITIS IS A GLOBAL PROBLEM AND IS DEFINED AS THE PRESENCE OF AT LEAST ONE OF THE FOLLOWING: congestion, rhinorrhea, sneezing, nasal itching, and nasal obstruction. The two major classifications are allergic and nonallergic rhinitis (NAR). Allergic rhinitis occurs when an allergen is the trigger for the nasal symptoms. NAR is when obstruction and rhinorrhea occurs in relation to nonallergic, n...
متن کاملPersistent Allergic Rhinitis and the XPERT Study
Allergic rhinitis (AR) is a chronic disease with an increasing trend in most of the Western Countries. It may significantly impair the individual quality of life (QoL) and also represents a social burden for its economic costs. Levocetirizine (XYZAL; UCB Pharma) as a second generation, nonsedating H1-antihistamine, has been shown to be clinically effective in patients with AR in different rando...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
iranian journal of otorhinolaryngologyجلد ۲۷، شماره ۴، صفحات ۲۵۳-۲۵۹
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023